|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-3-18
|
|
pubmed:abstractText |
Barrett's esophagus is mainly regarded as an acquired condition related to increased gastroesophageal reflux. Thus it is conceivable that abolition of acid reflux would lead to its regression. The aim of this study was to assess whether long-term treatment with high-dose omeprazole (60 mg/day) produces a consistent control of gastric acid production and normalizes the esophageal acid exposure, thus reducing the length of Barrett's epithelium.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0016-5107
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
700-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8979061-Anti-Ulcer Agents,
pubmed-meshheading:8979061-Barrett Esophagus,
pubmed-meshheading:8979061-Case-Control Studies,
pubmed-meshheading:8979061-Drug Administration Schedule,
pubmed-meshheading:8979061-Esophagoscopy,
pubmed-meshheading:8979061-Esophagus,
pubmed-meshheading:8979061-Female,
pubmed-meshheading:8979061-Follow-Up Studies,
pubmed-meshheading:8979061-Gastric Acidity Determination,
pubmed-meshheading:8979061-Humans,
pubmed-meshheading:8979061-Hydrogen-Ion Concentration,
pubmed-meshheading:8979061-Male,
pubmed-meshheading:8979061-Middle Aged,
pubmed-meshheading:8979061-Omeprazole,
pubmed-meshheading:8979061-Time Factors
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole.
|
|
pubmed:affiliation |
Università di Milano, Dipartimento di Medicina Interna, Italy.
|
|
pubmed:publicationType |
Journal Article
|
